Bio Rad Laboratories Inc/ US0905722072 /
2024-10-18 10:10:00 PM | Chg. +2.39 | Volume | Bid11:41:33 PM | Ask11:41:33 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
346.37USD | +0.69% | 190,992 Turnover: 27.69 mill. |
338.51Bid Size: 100 | 353.41Ask Size: 100 | 7.9 bill.USD | - | - |
GlobeNewswire
08-12
Oncocyte’s VitaGraft™ Kidney Used to Monitor Effect of Daratumumab on Anti-body Mediated Rejection i...
GlobeNewswire
06-24
Oncocyte Bolsters Executive Team with Key CFO Appointment: PRISM MarketView Highlights Strategic Lea...
GlobeNewswire
06-03
Breakthrough in Kidney Transplant Monitoring: PRISM MarketView Spotlights Oncocyte's VitaGraft Study
GlobeNewswire
2022-03-29
Fluidigm Announces Support Agreement with Caligan Partners Related to $250 Million Strategic Capital...
GlobeNewswire
2022-03-22
Iridia Announces Appointment of Thomas H. Cauley, Ph.D. as Vice President, Engineering
GlobeNewswire
2021-08-03
Rapid Micro Biosystems Announces Appointment of Melinda Litherland to Board of Directors
GlobeNewswire
2021-06-01
RNA Disease Diagnostics Further Strengthens Executive Leadership with Appointment of John W. Erickso...
GlobeNewswire
2020-08-24
Landec Nominates Three New Members to its Board of Directors, Providing Deep Expertise to Both Busin...
GlobeNewswire
2020-05-04
Alexis RIDEAU appointed Chief Executive Officer of DEINOVE with the ambition to strengthen the Comp...
Newsfile Corp
2020-04-16
LexaGene CEO Discusses COVID-19 Testing, Commercialization Strategy -- SECFilings.com
GlobeNewswire
2020-03-20
Natus Medical Announces the Appointment of Ilan Daskal to the Board of Directors
Newsfile Corp
2020-03-09
Coronavirus Highlights Need for Rapid Testing of Pathogens -- SECFilings.com